ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE
ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE
批准号:
7151129
负责人:
MURALI KRISHNA KAJA
金额:
$28.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-15 至 2008-11-30
关键词:
AcuteAnimalsAntigen-Presenting CellsAntigensAntiviral AgentsAntiviral ResponseBacterial InfectionsBiologicalBone MarrowCD8-Positive T-LymphocytesCD8B1 geneCellsClonal ExpansionConditionDataDoctor of PhilosophyEventExposure toFutureGenerationsGoalsHealthHumanImmuneImmune responseImmune systemImmunityImmunologic MemoryImmunologistIn VitroInfectionInfectious AgentInflammatoryInterferon Type IInterferonsKnowledgeLifeLightLymphocyteLymphocytic choriomeningitis virusLymphoid TissueMHC Class I GenesMaintenanceMediatingMemoryModelingMusNatural ImmunityNumbersOvalbuminPeptidesPhenotypePlayProcessResearchRoleSideSignal TransductionSpecificityStimulusStudy SectionT-Cell ActivationT-Cell ReceptorT-LymphocyteTestingThinkingTranscriptional ActivationTransgenic OrganismsUp-RegulationVaccinationVaccine DesignVaccinesViralVirusVirus DiseasesWorkbasecytokineimprovedin vivoinsightmouse modelpathogenreceptorreceptor expressionresearch studyresponsetype I interferon receptorvaccination strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term objectives of our research are to understand the mechanisms by which acute viral infections
induce potent immune responses with a hope that the knowledge gained from infectious models can be
applied for improving vaccination strategies. Our previous studies, using mouse models of lymphocytic
choriomeningitis virus (LCMV) infection, demonstrated that acute viral infections induce a much higher
magnitude of primary and memory CD8 T cell responses than was previously thought. We found that these
anti-viral memory CD8 cells persist for extended periods even in the absence of T cell receptor-MHC class I
interactions. Now it is becoming clear that some infections can elicit significant T cell responses even in the
absence of costimulatory molecules or professional APC help. The underlying mechanisms are not clear. To
better understand these mechanisms, we started characterizing possible events that may contribute to the
enhanced T cell response in viral infection. We found that infection-induced type-I interferons (IFNodl3)(a)
helps potentiate the CD8 T cell response and (b) cause a transient activation of na'fve T cells early after
infection. We hypothesize that this IFNcdl3 mediated sensitization of na'fve CD8 T cells may provide an
additional signal that potentiates the ability to respond to antigen. As a result, the na'fve CD8 T cells may
respond well even in the absence of co-stimulatory and or professional APC help under the conditions of
infection. This proposal is aimed at testing this by pursuing the following hypotheses: (1) that naive CD8 T
cells, upon sensitization by infection-induced IFNcdl3 may lower their activation threshold and respond better
to cognate antigenic stimulus, (2) that IFNcz/13receptorpositive (IFNRc_/13+/+)CD8 T cells may have a
selective advantage over receptor negative (IFNRcdl3-/-) CD8 T cells in eliciting immune response during
viral infection, and, (3) that IFNRcdl3+/+ CD8 T cells may become less dependent upon professional APC
help than IFNRcdI3-/- CD8 T cells during an anti-viral response.
These studies will provide insight into the biological consequences of bystander T cell activation in viral
infections and the mechanisms of cross-talk between innate and adaptive immunity. This work has
implications for improving vaccination strategies and provides groundwork for future studies aimed at
understanding the mechanisms involved in generation of immune memory and have significance for human
and animal health.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Novel Vaccination Strategies Against Epidemic and Pandemic Influenza Viruses to I
-
批准号:8318807
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2011
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
Novel Vaccination Strategies Against Epidemic and Pandemic Influenza Viruses to I
-
批准号:8227808
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2011
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
Novel Vaccination Strategies Against Epidemic and Pandemic Influenza Viruses to I
-
批准号:7924111
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2009
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
IFN actions and immune cell activation by West Nile Virus
-
批准号:7746285
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2009
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
Novel Vaccination Strategies Against Epidemic and Pandemic Influenza Viruses to I
-
批准号:7651908
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2009
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
CD8 T-CELL RESPONSE
-
批准号:6971730
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2004
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE
-
批准号:6690369
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2002
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE
-
批准号:6558051
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2002
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE
-
批准号:6986779
-
项目类别:
-
资助金额:$29.61万
-
财政年份:2002
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE
-
批准号:6828235
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2002
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
Potentiation Immune Resp vs HIV vacc Modula Innate Resp
-
批准号:6461627
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2001
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
Potentiation Immune Resp vs HIV vacc Modula Innate Resp
-
批准号:6511830
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2001
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
IFN actions and immune cell activation by West Nile Virus
-
批准号:8261946
-
项目类别:
-
资助金额:$31.17万
-
财政年份:--
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
IFN actions and immune cell activation by West Nile Virus
-
批准号:8070390
-
项目类别:
-
资助金额:$30.87万
-
财政年份:--
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
IFN actions and immune cell activation by West Nile Virus
-
批准号:8459421
-
项目类别:
-
资助金额:$28.18万
-
财政年份:--
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
IFN actions and immune cell activation by West Nile Virus
-
批准号:8375810
-
项目类别:
-
资助金额:$31.86万
-
财政年份:--
-
负责人:MURALI KRISHNA KAJA
-
依托单位:
海外基金